BOSTON--(BUSINESS WIRE)--
Please replace the release with the following corrected version due to
multiple revisions.
The corrected release reads:
INFOBIONIC HAS ENTERED INTO AN EXCLUSIVE DISTRIBUTORSHIP WITH
BIOTRONIK FOR MOME® KARDIA IN THE U.S.; EXPECTS
SIGNIFICANT NATIONWIDE GROWTH
InfoBionic, a digital health company focused on creating next generation
solutions for ambulatory cardiac arrhythmia monitoring, has announced
that it has entered into an exclusive distributorship to make BIOTRONIK,
a global leader in cardio- and endovascular medical technology, the
exclusive distributor of MoMe® Kardia in the U.S.
MoMe® Kardia is the first and only deep learning Software as
a Service (SaaS) remote cardiac monitoring platform that replicates
in-hospital monitoring with full disclosure cardiac data delivered
direct to physicians for 24/7 on-demand review via a HIPAA-compliant
portal. By giving physicians control of when, where, and how they review
monitoring reports – as well as access to beat-to-beat data to verify
events – MoMe® Kardia can significantly reduce time to
diagnosis and intervention. The innovative model also positively impacts
practice economics by giving physicians full ownership of monitoring
services.
Speaking to the benefits his practice has seen since using the MoMe®
Kardia system, Matthew B. Hillis, MD, FACC, FHRS of Marple Medical
Associates in Broomall, Pennsylvania explains: “The workflow has been
more efficient for us from both the staff and physician perspective.
Customizable alerts, utilization tracking/inventory management, improved
patient comfort, and compliance have been beneficial. The quality of ECG
tracings is high, and we have found the business model to be useful as
well.”
“BIOTRONIK is a prestigious and trusted cardiovascular solutions
technology provider in the industry, and this distribution agreement
will not only allow us to expand access to MoMe® Kardia
nationwide, but reinforces that leaders in our market recognize the
clinical value of the system,” said Stuart Long, CEO of InfoBionic.
“Through this partnership we will enable more physicians and practices
to take back ownership of ambulatory cardiac monitoring services so that
they can speed decision-making and diagnosis and provide a better
patient experience.”
About InfoBionic
InfoBionic is a digital health company focused on creating next
generation patient monitoring solutions for chronic disease management
with an initial market focus on cardiac arrhythmias. InfoBionic’s lead
product, MoMe® Kardia, is the only remote cardiac arrhythmia
detection and monitoring system that replicates in-hospital telemetry
data, right in the office, by giving physicians 24/7 on-demand access to
full disclosure Holter, Event, and MCT data via a HIPAA-compliant portal
app. For more information, visit www.infobionic.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180828005138/en/
InfoBionic
Carla Nieser, 610-240-0400, ext. 108
c.nieser@voveo.com
Source: InfoBionic